The progression of glioblastomas is associated with a variety of neurological impairments,
such as tumor-related epileptic seizures. Seizures are not only a common comorbidity of …

Existing guidelines on the preparation (Planning Research and Experimental Procedures on
Animals: Recommendations for Excellence (PREPARE)) and reporting (Animal Research …

Glioblastoma (GBM) is the most common and advanced form of primary malignant tumor
occurring in the adult central nervous system, and it is frequently associated with epilepsy, a …

Aquaporins (AQPs) are a family of membrane proteins involved in the transport of water and
ions across cell membranes. AQPs have been shown to be implicated in various …

Background: Gliomas are the most malignant tumors of the nervous system. Even though
their survival outcome is closely affected by immune-related genes (IRGs) in the tumor …

Low‐grade neuroepithelial tumors (LGNTs), particularly those with glioneuronal histology,
are highly associated with pharmacoresistant epilepsy. Increasing research focused on …

Glioblastoma (GB), a highly aggressive primary brain tumor, presents a poor prognosis
despite the current standard therapy, including radiotherapy and temozolomide (TMZ) …

Background Glioblastoma multiforme (GBM) is the most malignant brain tumor, with a poor
prognosis and life expectancy of 14–16 months after diagnosis. The standard treatment for …

Background: Gliomas, especially high-grade gliomas, are highly malignant with a poor
prognosis. Although existing treatments have improved the survival rate of patients with …

Magnetic resonance imaging (MRI) is frequently used for preclinical treatment monitoring in
glioblastoma (GB). Discriminating between tumors and tumor-associated changes is …